Vitaspring Biomedical VSBC
OTC VSBC
$0.03 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Operating Leases (2021 - 2023)

Updated

Vitaspring Biomedical's Operating Leases came in at $93,334 for fiscal Q4 2023 (quarter ended Jan 31, 2023), down 67.0% from $282,469 a year earlier.

Analysis

Vitaspring Biomedical (VSBC) Operating Leases (2021 - 2023) Analysis & Trends

  • Going back by fiscal year, Operating Leases was $282,469 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Vitaspring Biomedical 6.21 Mn 6.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2023 93,334.00
Jan 31, 2022 282,469.00
Oct 31, 2021 329,634.00
API Access

Vitaspring Biomedical Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=VSBC&period=max&api_key=YOUR_API_KEY